I'm still kind of puzzled how did the examiner omit the biggest part of the claim which was 90% vs. 30% and claiming it as not-innovative and infringing. But I also like the response from our Patent Attorneys.
(0)
(0)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links